France vs Togo: Share of people with HIV who receive antiretroviral therapy
France
91.0%
in 2022
Togo
92.0%
in 2024
France rank
17th
Togo rank
14th
Share of people with HIV who receive antiretroviral therapy over time
- France
- Togo
How they compare
Togo currently reports 92.0% against 91.0% in France, a difference of 1.0%.
Across all 23 years both countries report, France has been ahead every year.
France ranks 17th and Togo ranks 14th of 143 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.9% | 4.6% | 75.3% | France |
| 2010s | 88.0% | 44.8% | 43.2% | France |
| 2020s | 90.0% | 80.3% | 9.7% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, France or Togo?
- Togo, at 92.0% against 91.0% in France as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between France and Togo?
- 1.0%, with Togo ahead.
- How many years of comparable data are there for France and Togo?
- 23 years are reported by both, from 2000 to 2022.
- How do France and Togo rank globally for share of people with hiv who receive antiretroviral therapy?
- France ranks 17th and Togo ranks 14th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.